海洋Nocardiopsis sp. ZSN1非甾体FXR激动性二聚体2-甲基-4-(1-甘油)呋喃降脂活性

IF 4.9 2区 医学 Q1 CHEMISTRY, MEDICINAL
Marine Drugs Pub Date : 2025-02-20 DOI:10.3390/md23030092
Yongjun Jiang, Zhen Lei, Jiebin Fang, Yanping Wu, Chengpeng Sun
{"title":"海洋Nocardiopsis sp. ZSN1非甾体FXR激动性二聚体2-甲基-4-(1-甘油)呋喃降脂活性","authors":"Yongjun Jiang, Zhen Lei, Jiebin Fang, Yanping Wu, Chengpeng Sun","doi":"10.3390/md23030092","DOIUrl":null,"url":null,"abstract":"<p><p>Five novel 2-methyl-4-(1-glycerol)furan (MGF) dimers, namely nocardifuran A (<b>1</b>), 13-<i>acetyl</i>-nocardifuran A (<b>2</b>), 15-<i>epi</i>-nocardifuran A (<b>3</b>), nocardifuran B (<b>4</b>), and nocardifuran C (<b>5</b>), were isolated from the Gause liquid fermentation of the marine-derived <i>Nocardiopsis</i> sp. ZSN1. Their structures were elucidated through HRESIMS, 1D and 2D NMR spectroscopic data analysis, and ECD calculations. Compounds <b>1</b>-<b>4</b> were identified as derivatives of MGF with its rearrangement of furan or pyran derivatives, while compound <b>5</b> was identified as the derivative of MGF with an indole derivative. These MGF dimers, representing a new structural class, were isolated from a marine microorganism for the first time, thereby enhancing chemical diversity. Screening for farnesoid X receptor (FXR) agonistic activity revealed that MGF dimers could activate FXR. Furthermore, bioactivity evaluations demonstrated that these types of compounds exhibited lipid-lowering activity with lower cytotoxicity in vitro. Consequently, our findings not only contribute to the chemical diversity of marine-derived MGF-type natural products but also offer potential insights into the development of MGF dimers as lead compounds for FXR agonists in the dysregulation of hepatic lipid metabolism.</p>","PeriodicalId":18222,"journal":{"name":"Marine Drugs","volume":"23 3","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11944181/pdf/","citationCount":"0","resultStr":"{\"title\":\"Non-Steroidal FXR Agonistic Dimeric 2-Methyl-4-(1-glycerol)furan with Lipid-Lowering Activities from Marine-Derived <i>Nocardiopsis</i> sp. ZSN1.\",\"authors\":\"Yongjun Jiang, Zhen Lei, Jiebin Fang, Yanping Wu, Chengpeng Sun\",\"doi\":\"10.3390/md23030092\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Five novel 2-methyl-4-(1-glycerol)furan (MGF) dimers, namely nocardifuran A (<b>1</b>), 13-<i>acetyl</i>-nocardifuran A (<b>2</b>), 15-<i>epi</i>-nocardifuran A (<b>3</b>), nocardifuran B (<b>4</b>), and nocardifuran C (<b>5</b>), were isolated from the Gause liquid fermentation of the marine-derived <i>Nocardiopsis</i> sp. ZSN1. Their structures were elucidated through HRESIMS, 1D and 2D NMR spectroscopic data analysis, and ECD calculations. Compounds <b>1</b>-<b>4</b> were identified as derivatives of MGF with its rearrangement of furan or pyran derivatives, while compound <b>5</b> was identified as the derivative of MGF with an indole derivative. These MGF dimers, representing a new structural class, were isolated from a marine microorganism for the first time, thereby enhancing chemical diversity. Screening for farnesoid X receptor (FXR) agonistic activity revealed that MGF dimers could activate FXR. Furthermore, bioactivity evaluations demonstrated that these types of compounds exhibited lipid-lowering activity with lower cytotoxicity in vitro. Consequently, our findings not only contribute to the chemical diversity of marine-derived MGF-type natural products but also offer potential insights into the development of MGF dimers as lead compounds for FXR agonists in the dysregulation of hepatic lipid metabolism.</p>\",\"PeriodicalId\":18222,\"journal\":{\"name\":\"Marine Drugs\",\"volume\":\"23 3\",\"pages\":\"\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11944181/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Marine Drugs\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/md23030092\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Marine Drugs","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/md23030092","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

摘要

从海洋源Nocardiopsis sp. ZSN1的Gause液体发酵中分离出5个新的2-甲基-4-(1-甘油)呋喃(MGF)二聚体,分别为nocardifuran A(1)、13-乙酰-nocardifuran A(2)、15-epi-nocardifuran A(3)、nocardifuran B(4)和nocardifuran C(5)。通过hresms、1D和2D NMR数据分析以及ECD计算对其结构进行了分析。化合物1-4为呋喃或吡喃衍生物重排的MGF衍生物,化合物5为含吲哚衍生物的MGF衍生物。这些MGF二聚体是首次从海洋微生物中分离到的一种新的结构类别,从而增强了其化学多样性。筛选法脂类X受体(FXR)的拮抗活性发现MGF二聚体可以激活FXR。此外,生物活性评价表明,这些类型的化合物具有降脂活性,体外细胞毒性较低。因此,我们的研究结果不仅有助于海洋来源的MGF型天然产物的化学多样性,而且还为开发MGF二聚体作为FXR激动剂在肝脏脂质代谢失调中的先导化合物提供了潜在的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Non-Steroidal FXR Agonistic Dimeric 2-Methyl-4-(1-glycerol)furan with Lipid-Lowering Activities from Marine-Derived Nocardiopsis sp. ZSN1.

Five novel 2-methyl-4-(1-glycerol)furan (MGF) dimers, namely nocardifuran A (1), 13-acetyl-nocardifuran A (2), 15-epi-nocardifuran A (3), nocardifuran B (4), and nocardifuran C (5), were isolated from the Gause liquid fermentation of the marine-derived Nocardiopsis sp. ZSN1. Their structures were elucidated through HRESIMS, 1D and 2D NMR spectroscopic data analysis, and ECD calculations. Compounds 1-4 were identified as derivatives of MGF with its rearrangement of furan or pyran derivatives, while compound 5 was identified as the derivative of MGF with an indole derivative. These MGF dimers, representing a new structural class, were isolated from a marine microorganism for the first time, thereby enhancing chemical diversity. Screening for farnesoid X receptor (FXR) agonistic activity revealed that MGF dimers could activate FXR. Furthermore, bioactivity evaluations demonstrated that these types of compounds exhibited lipid-lowering activity with lower cytotoxicity in vitro. Consequently, our findings not only contribute to the chemical diversity of marine-derived MGF-type natural products but also offer potential insights into the development of MGF dimers as lead compounds for FXR agonists in the dysregulation of hepatic lipid metabolism.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Marine Drugs
Marine Drugs 医学-医药化学
CiteScore
9.60
自引率
14.80%
发文量
671
审稿时长
1 months
期刊介绍: Marine Drugs (ISSN 1660-3397) publishes reviews, regular research papers and short notes on the research, development and production of drugs from the sea. Our aim is to encourage scientists to publish their experimental and theoretical research in as much detail as possible, particularly synthetic procedures and characterization information for bioactive compounds. There is no restriction on the length of the experimental section.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信